About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars Virtual Tours
BioDuro Increases Spray Dried Drug Product Manufacturing Capacity
San Diego, Nov. 8, 2016 – PR Newswire – BioDuro, LLC, announced today the addition of an SPX Anhydro MicraSpray 150, to its suite of established GMP spray drying capabilities that include an SPX Anhyd
November 08, 2016
Sundia Selected as a Red Herring Top 100 Asia Company
Shanghai, September 14, 2016 – Sundia MediTech Company, Ltd. (“Sundia”) today announced that it has been selected as a winner of Red Herring’s 2016 Top 100 Asia award. Sundia, a leading pre-clinical contract research organization (
September 14, 2016
Sundia congratulates Betta Pharmaceuticals for X-396 IND approval in China
Shanghai, August 31, 2016 – Betta Pharmaceuticals Co., Ltd. has successfully received X-396 CFDA IND approval in the class 1.1 IND application. The innovative target therapy, X-396, is aim to provide treatments f
August 31, 2016
BioDuro Completes Infrastructure Expansion in Shanghai
Shanghai, August 25, 2016 – PRNewswire – BioDuro, LLC, a global life science research and development organization today announced completion of a significant expansion to its 92,000 square f
August 25, 2016
BioDuro Launches as Unique Contract Research and Drug Manufacturing Organization
SAN DIEGO, June 6, 2016 – BioDuro, LLC, a global contract research organization (CRO) focused on fully outsourced turnkey discovery and development services in Oncology, Inflammatory Di
June 06, 2016
Total 84 12...91011121314151617
NASH Webinar Coming Soon
Register Today! This online event "Unleashing Innovation: A New Obesogenic NASH Model with High Clinically Translational Power" translates NASH/NAFLD research to clinic with better representative data, faster.
View more
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all